Oral lichen planus following the administration of vector-based COVID-19 vaccine (Ad26.COV2.S)

被引：37
|
作者：
Troeltzsch, Matthias [1 ,2 ]
Gogl, Markus [2 ]
Berndt, Ronald [3 ]
Troeltzsch, Markus [2 ]
机构：
[1] Ludwig Maximilians Univ Munchen, Univ Hosp, Dept Oral & Maxillofacial Surg & Facial Plast Sur, Lindwurmstr 2a, D-80337 Munich, Germany
[2] Ctr Oral Maxillofacial & Facial Reconstruct Surg, Ansbach, Germany
[3] Ansbach Gen Hosp, Dept Pathol, Ansbach, Germany
来源：
ORAL DISEASES | 2022年 / 28卷
关键词：
Ad26.COV2.S; COVID vaccine; COVID-19; oral lichen planus;
D O I：
10.1111/odi.14025
中图分类号：
R78 [口腔科学];
学科分类号：
1003 ;
摘要：
引用
收藏
页码：2595 / 2596
页数：2
相关论文
共 50 条
  • [1] Comment on "Oral lichen planus following the administration of vector based COVID-19 vaccine (Ad26.COV2.S)". Authors' reply
    Troeltzsch, Matthias
    Berndt, Ronald
    Troeltzsch, Markus
    ORAL DISEASES, 2022, 28 : 2610 - 2611
  • [2] Immunogenicity and efficacy of Ad26.COV2.S: An adenoviral vector-based COVID-19 vaccine
    Le Gars, Mathieu
    Hendriks, Jenny
    Sadoff, Jerry
    Ryser, Martin
    Struyf, Frank
    Douoguih, Macaya
    Schuitemaker, Hanneke
    IMMUNOLOGICAL REVIEWS, 2022, 310 (01) : 47 - 60
  • [3] Immunogenicity of the Ad26.COV2.S Vaccine for COVID-19
    Stephenson, Kathryn E.
    Le Gars, Mathieu
    Sadoff, Jerald
    de Groot, Anne Marit
    Heerwegh, Dirk
    Truyers, Carla
    Atyeo, Caroline
    Loos, Carolin
    Chandrashekar, Abishek
    McMahan, Katherine
    Tostanoski, Lisa H.
    Yu, Jingyou
    Gebre, Makda S.
    Jacob-Dolan, Catherine
    Li, Zhenfeng
    Patel, Shivani
    Peter, Lauren
    Liu, Jinyan
    Borducchi, Erica N.
    Nkolola, Joseph P.
    Souza, Morgana
    Tan, Chen Sabrina
    Zash, Rebecca
    Julg, Boris
    Nathavitharana, Ruvandhi R.
    Shapiro, Roger L.
    Azim, Ahmed Abdul
    Alonso, Carolyn D.
    Jaegle, Kate
    Ansel, Jessica L.
    Kanjilal, Diane G.
    Guiney, Caitlin J.
    Bradshaw, Connor
    Tyler, Anna
    Makoni, Tatenda
    Yanosick, Katherine E.
    Seaman, Michael S.
    Lauffenburger, Douglas A.
    Alter, Galit
    Struyf, Frank
    Douoguih, Macaya
    Van Hoof, Johan
    Schuitemaker, Hanneke
    Barouch, Dan H.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2021, 325 (15): : 1535 - 1544
  • [4] Massive bullous local reaction following administration of Ad26.COV2.S COVID-19 vaccine
    Montero-Menarguez, Julia
    Falkenhain-Lopez, Daniel
    Guzman-Perez, Luisa Maria
    Rodriguez-Peralto, Jose Luis
    Tous-Romero, Fatima
    Gallego-Alvarez, Silvia
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 2022, 61 (05) : 636 - 638
  • [5] Analysis of the Effectiveness of the Ad26.COV2.S Adenoviral Vector Vaccine for Preventing COVID-19
    Corchado-Garcia, Juan
    Zemmour, David
    Hughes, Travis
    Bandi, Hari
    Cristea-Platon, Tudor
    Lenehan, Patrick
    Pawlowski, Colin
    Bade, Sairam
    O'Horo, John C.
    Gores, Gregory J.
    Williams, Amy W.
    Badley, Andrew D.
    Halamka, John
    Virk, Abinash
    Swift, Melanie D.
    Wagner, Tyler
    Soundararajan, Venky
    JAMA NETWORK OPEN, 2021, 4 (11) : e2132540
  • [6] Rhabdomyolysis Following Ad26.COV2.S COVID-19 Vaccination
    Gelbenegger, Georg
    Cacioppo, Filippo
    Firbas, Christa
    Jilma, Bernd
    VACCINES, 2021, 9 (09)
  • [7] Acute disseminated encephalomyelitis following the COVID-19 vaccine Ad26.COV2.S, a case report
    Stefan Gustavsen
    Mette Maria Nordling
    Arkadiusz Weglewski
    Bulletin of the National Research Centre, 47 (1)
  • [8] Bell's palsy following the Ad26.COV2.S COVID-19 vaccination
    Nishizawa, Y.
    Hoshina, Y.
    Baker, V
    QJM-AN INTERNATIONAL JOURNAL OF MEDICINE, 2021, 114 (09) : 657 - 658
  • [9] Ad26.COV2.S COVID-19 vaccine: TTS a rare, but serious adverse event
    Reactions Weekly, 2022, 1891 (1) : 2 - 2
  • [10] Lymphohistocytic myocarditis after Ad26.COV2.S viral vector COVID-19 vaccination
    Ujueta, Francisco
    Azimi, Roshanak
    Lozier, Matthew R.
    Poppiti, Robert
    Ciment, Ari
    IJC HEART & VASCULATURE, 2021, 36
12345